Author:
Abdel-Rahman Omar,Fouad Mona
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference40 articles.
1. Aaltonen L, Hamilton S (2000) World Health Organization. Oxford, International Agency for Research on Cancer. Pathology and genetics of tumours of the digestive system. IARC Press; Oxford University Press Distributor, Lyon
2. Abdel-Rahman O, Fouad M (2014) Risk of mucocutaneous toxicities in patients with solid tumors treated with sorafenib; an updated systematic review and meta-analysis. Expert Rev Anticancer Ther [Epub ahead of print]
3. Abdel-Rahman O, Abdelwahab M, Shaker M, AbdelWahab S, Elbassiony M, Ellithy M (2013) Sorafenib versus capecitabine in the management of advanced hepatocellular carcinoma. Med Oncol (3):655. doi: 10.1007/s12032-013-0655-z . Epub 2013 Jul 4
4. Berruti A, Fazio N, Ferrero A, Brizzi MP, Volante M, Nobili E et al (2014) Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the xelbevoct study. BMC Cancer 14(1):184. doi: 10.1186/1471-2407-14-184
5. Bosman F (2010), World Health Organization, International Agency for Research on Cancer. WHO classification of tumours of the digestive system. (4th ed.)International Agency for Research on Cancer, Lyon
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献